Literature DB >> 8903387

Fibrolamellar carcinoma of the liver: composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules.

J Y Scoazec1, J F Flejou, A D'Errico, M Fiorentino, A Zamparelli, A F Bringuier, G Feldmann, W F Grigioni.   

Abstract

We have analyzed the composition of the tumor stroma and the expression of cell-matrix and cell-cell adhesion molecules in 11 cases of fibrolamellar carcinoma of the liver (FLC), in comparison with 34 cases of hepatocellular carcinoma and 8 cases of focal nodular hyperplasia. Fibrolamellar carcinoma was characterized by the presence of large amounts of tenascin in tumor stroma and by the scarce expression of basement membrane components at the contact of neoplastic clusters. Like normal hepatocytes, neoplastic cells constantly expressed the alpha1 integrin chain, lacked the beta4 integrin chain, and coexpressed E-cadherin and the hepatocyte N-related cadherin. Abnormalities in the expression of cell adhesion molecules, including altered cadherin expression, alphaV integrin chain induction, and CD44 expression, were detected in the majority of cases. The composition of the tumor stroma and the pattern of expression of cell adhesion molecules in fibrolamellar carcinoma were reminiscent of those observed in grade III and grade IV hepatocellular carcinomas. Our results therefore show that, despite its slow local growth and good prognosis, fibrolamellar carcinoma expresses many characteristics usually associated with clinically aggressive malignancies. Further studies are needed to identify the factors responsible for the apparent dissociation between clinical behavior and biological characteristics in this tumor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903387     DOI: 10.1002/hep.510240525

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.

Authors:  Gianluigi Giannelli; Emilia Fransvea; Felice Marinosci; Carlo Bergamini; Silvia Colucci; Oronzo Schiraldi; Salvatore Antonaci
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

2.  S-phase delay in human hepatocellular carcinoma cells induced by overexpression of integrin beta1.

Authors:  Yu-Long Liang; Ting-Wen Lei; Heng Wu; Jian-Min Su; Li-Ying Wang; Qun-Ying Lei; Xi-Liang Zha
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  Transforming growth factor beta controls the directional migration of hepatocyte cohorts by modulating their adhesion to fibronectin.

Authors:  Fabien Binamé; Patrice Lassus; Urszula Hibner
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

4.  CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production.

Authors:  Yonglin Chen; Hui Peng; Yongyan Chen; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

5.  MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma.

Authors:  Timothy A Dinh; Mark L Jewell; Matt Kanke; Adam Francisco; Ramja Sritharan; Rigney E Turnham; Seona Lee; Edward R Kastenhuber; Eliane Wauthier; Cynthia D Guy; Raymond S Yeung; Scott W Lowe; Lola M Reid; John D Scott; Anna M Diehl; Praveen Sethupathy
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-02-11

Review 6.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.